 Zynerba Pharmaceuticals Inc NASDAQ:ZYNE has announced an oral presentation at the Society for the Study of Behavioural Phenotypes 24th International Research Symposium, being held in Oslo, Norway, from September 8 to 10. Helen Honey Heussler, an associate professor in the Faculty of Medicine at the Child Health Research Centre, University of Queensland, Australia, presented data from the open-label phase 2 INSPIRE trial. 